1. Home
  2. KBSX vs SER Comparison

KBSX vs SER Comparison

Compare KBSX & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FST Corp. Ordinary Shares

KBSX

FST Corp. Ordinary Shares

N/A

Current Price

$1.08

Market Cap

50.6M

ML Signal

N/A

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$2.57

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBSX
SER
Founded
1976
2017
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.6M
42.0M
IPO Year
2024
2024

Fundamental Metrics

Financial Performance
Metric
KBSX
SER
Price
$1.08
$2.57
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
10.3K
54.5K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$130,000.00
Revenue This Year
$18.65
N/A
Revenue Next Year
$16.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
132.14
52 Week Low
$0.81
$1.22
52 Week High
$1.77
$5.83

Technical Indicators

Market Signals
Indicator
KBSX
SER
Relative Strength Index (RSI) 49.81 54.62
Support Level $0.82 $2.51
Resistance Level $1.03 $2.95
Average True Range (ATR) 0.10 0.22
MACD 0.00 -0.03
Stochastic Oscillator 50.00 49.49

Price Performance

Historical Comparison
KBSX
SER

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

Share on Social Networks: